Xconomy Xchange: New York's Life Science Disruptors
AGENDA
4:30 – 5:30 Registration
5:30 – 5:40
Welcome
Bob Buderi, Founder and Editor in Chief, Xconomy
Chris Otey, Senior Director, Life Science, Alexandria Real Estate Equities
5:40 – 5:50 Opening Remarks
Ron Cohen, CEO, Acorda Therapeutics
5:50 – 6:15
University/Research Perspective
Marc Tessier-Lavigne
, President, Rockefeller University
Eric Schadt, Director, The Icahn Institute for Genetics and Multiscale Biology
Ron Cohen, CEO, Acorda Therapeutics (moderator)
6:15 – 6:35 Investor Perspective
Alex Denner
, Founding Partner, Sarissa Capital Management
Meg Tirrell, Biotechnology Reporter, Bloomberg News (moderator)
6:35 – 7:00
Industry Perspective
George Golumbeski
, Senior Vice President, Business Development, Celgene
Francois Nader, President and Chief Executive Officer, NPS Pharmaceuticals
Ron Cohen, CEO, Acorda Therapeutics (moderator)
7:00 – 8:00 Networking Reception
REGISTER NOW: xconomyxchange11.eventbrite.com